Stay updated with breaking news from Michellea rudek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers ....
PI3K/AKT/mTOR Inhibitors for Prostate Cancer – Finally Hints of a Breakthrough Published 05 January 2021 Activation of the phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway has been strongly linked with prostate cancer progression and metastatic potential. 1 Loss of the inhibitory phosphatase, PTEN, leading to hyperactivation of PI3K/AKT/mTOR oncogenic signaling, occurs in 40-50% of metastatic castration-resistant prostate cancer. 1,2 Not surprising is the fact that PTEN loss in patients with metastatic castration-resistant prostate cancer is associated with a worse prognosis and less benefit from androgen receptor (AR) blockade. 3 Likewise, PTEN loss and subsequent Akt activation confer radiation ....